Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Gerdes

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Medical Virology|December 19, 2023
Limited antibody response after BA.4-5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: Results of a case seriesUlf M Geisen, Mathias Voß, Ruben Rose, et al.
Annals of the Rheumatic Diseases|March 25, 2021
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortUlf M Geisen, Dennis K Berner, Florian Tran, et al.
American Journal of Clinical Dermatology|April 15, 2025
Burden to Partners of People with Psoriasis: Results from the FamilyPso International StudyUlrich Mrowietz, Crispin Meyer, Katja Großschädl, et al.
Allergy|July 25, 2024
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccinationJana Sophia Buhre, Tamas Pongracz, Ulf Martin Geisen, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2020
Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responsesLam C Tsoi, Elke Rodriguez, Dora Stölzl, et al.
The Journal of Investigative Dermatology|February 20, 2021
Genetic Analysis of MPO Variants in Four Psoriasis Subtypes in Patients from GermanyStefan Haskamp, Joseph Simon Horowitz, Vinzenz Oji, et al.
Skin Health and Disease|November 28, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermanyLuise Heinrich, Thomas Birkner, Susanne Abraham, et al.
The British Journal of Dermatology|July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsLinda Stein Gold, April W Armstrong, Jennifer Soung, et al.
Journal of Advanced Research|May 17, 2022
Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of diseaseMeriem Belheouane, Britt M Hermes, Nina Van Beek, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Medical Virology|December 19, 2023
Limited antibody response after BA.4-5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: Results of a case seriesUlf M Geisen, Mathias Voß, Ruben Rose, et al.
Annals of the Rheumatic Diseases|March 25, 2021
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortUlf M Geisen, Dennis K Berner, Florian Tran, et al.
American Journal of Clinical Dermatology|April 15, 2025
Burden to Partners of People with Psoriasis: Results from the FamilyPso International StudyUlrich Mrowietz, Crispin Meyer, Katja Großschädl, et al.
Allergy|July 25, 2024
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccinationJana Sophia Buhre, Tamas Pongracz, Ulf Martin Geisen, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2020
Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responsesLam C Tsoi, Elke Rodriguez, Dora Stölzl, et al.
The Journal of Investigative Dermatology|February 20, 2021
Genetic Analysis of MPO Variants in Four Psoriasis Subtypes in Patients from GermanyStefan Haskamp, Joseph Simon Horowitz, Vinzenz Oji, et al.
Skin Health and Disease|November 28, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermanyLuise Heinrich, Thomas Birkner, Susanne Abraham, et al.
The British Journal of Dermatology|July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsLinda Stein Gold, April W Armstrong, Jennifer Soung, et al.
Journal of Advanced Research|May 17, 2022
Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of diseaseMeriem Belheouane, Britt M Hermes, Nina Van Beek, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 11